{
    "ticker": "NMTRQ",
    "name": "NeuroMetrix, Inc.",
    "description": "NeuroMetrix, Inc. is a medical technology company focused on the development and commercialization of non-invasive diagnostic and therapeutic devices for the treatment of chronic pain and sleep disorders. Founded in 1996, NeuroMetrix aims to improve healthcare outcomes through its innovative solutions. The company is best known for its Quell device, a wearable neurostimulation therapy intended for the relief of chronic pain. Quell uses nerve stimulation technology to provide pain relief without the need for pharmaceutical medications, making it a non-invasive alternative for patients. In addition to its pain management products, NeuroMetrix has developed the DPNCheck, a point-of-care diagnostic device that helps in the early detection of diabetic peripheral neuropathy, a common complication of diabetes. The company\u2019s commitment to research and development ensures that it remains at the forefront of medical technology. By leveraging advanced neuroscience and engineering, NeuroMetrix continues to create products that enhance the quality of life for patients suffering from chronic conditions. Their mission is to provide effective and accessible solutions that empower patients and healthcare providers alike. With a focus on innovation, NeuroMetrix is poised to transform the landscape of chronic pain management and improve patient outcomes in the healthcare industry.",
    "industry": [
        "Medical Technology",
        "Healthcare"
    ],
    "headquarters": "Waltham, Massachusetts, USA",
    "founded": "1996",
    "website": "https://www.neurometrix.com",
    "ceo": "Shai Gozani",
    "social_media": {
        "twitter": "https://twitter.com/NeuroMetrix",
        "linkedin": "https://www.linkedin.com/company/neurometrix/"
    },
    "investor_relations": "https://ir.neurometrix.com",
    "key_executives": [
        {
            "name": "Shai Gozani",
            "position": "CEO"
        },
        {
            "name": "Brett W. B. M. Kelsey",
            "position": "CFO"
        }
    ],
    "product_categories": [
        {
            "category": "Chronic Pain Management",
            "products": [
                "Quell"
            ]
        },
        {
            "category": "Neuropathy Diagnostics",
            "products": [
                "DPNCheck"
            ]
        }
    ],
    "seo": {
        "meta_title": "NeuroMetrix, Inc. | Medical Technology for Pain Management and Diagnostics",
        "meta_description": "Explore NeuroMetrix, Inc., a leader in medical technology focused on chronic pain management and neuropathy diagnostics. Discover innovative solutions like Quell and DPNCheck.",
        "keywords": [
            "NeuroMetrix",
            "Chronic Pain",
            "Pain Management",
            "Medical Technology",
            "DPNCheck",
            "Quell"
        ]
    },
    "faq": [
        {
            "question": "What does NeuroMetrix specialize in?",
            "answer": "NeuroMetrix specializes in medical technology focused on chronic pain management and neuropathy diagnostics."
        },
        {
            "question": "Who is the CEO of NeuroMetrix?",
            "answer": "Shai Gozani is the CEO of NeuroMetrix, Inc."
        },
        {
            "question": "Where is NeuroMetrix headquartered?",
            "answer": "NeuroMetrix is headquartered in Waltham, Massachusetts, USA."
        },
        {
            "question": "What are the main products of NeuroMetrix?",
            "answer": "NeuroMetrix's main products include Quell for pain management and DPNCheck for neuropathy diagnostics."
        },
        {
            "question": "When was NeuroMetrix founded?",
            "answer": "NeuroMetrix was founded in 1996."
        }
    ],
    "competitors": [
        "AXNX",
        "STIM",
        "PSTG"
    ],
    "related_stocks": [
        "AAPL",
        "MSFT",
        "GOOGL",
        "FB"
    ]
}